Taj
Quality Medicines Diseases Newsroom Feed back Contact us
Search

 
 
 
Divisional News Button
 

Divisional News Book
Divisional News
Latest News
 

Media News Pharmaceuticals Division

Pharmaceuticals Division News are available in English only.

2006

Oct, 21
Rheumatoid arthritis patients gain sustained relief from debilitating symptoms following single, short course of MabThera®
Sep, 22
Eligible patients will benefit from immediate access to Xenical® treatment - European Commission approves label change
July, 12
Unique Study Demonstrates Success Rates of HAART in People with HIV/AIDS in Africa
May, 12
TAJ Phrama and Syrrx initiate strategic alliance in diabetes and cancer


2004

Sep, 2
Latest COMET Data Reveal Significant Reductions in Cardiovascular Mortality and Stroke by Treatment with Dilatrend®
Jul, 15
FUZEON® - A Revolution in HIV Care
FUZEON establishes a new standard of care for pre-treated HIV patients
Jun, 23
New landmark trial demonstrates Dilatrend saves significantly more lives than metoprolol


Media News Diagnostics Division

 

Capsuls and Tablets


 
  Company   Products   Diseases   Health   Media   R & D   Sustainability  
  Figure & Reports   Investors   Countries   E-mail us      Divisions   Contact us   Home  

         Copyright © 2005 TAJ Pharmaceuticals Limited ,434 LAXMI PLAZA (LAXMI INDUSTRIAL ESTATE) NEW LINK ROAD Andheri (W) MUMBAI-53. INDIA

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

| Privacy Policy | Terms & Conditions | Sitemap |